A common therapeutic plant in traditional medical systems, Achyranthes aspera Linn. has attracted more scientific attention due to its many pharmacological characteristics, including its capacity to reduce inflammation and produce antioxidants. Chronic inflammation and oxidative stress are characteristics of CVDs, which remain the leading cause of morbidity and death globally. The bioactive phytoconstituents of A. asperaare thoroughly examined in this study along with their mechanistic functions in reducing oxidative damage and inflammatory cascades linked to the pathophysiology of CVD. Preclinical research, in vitro tests, and scant clinical knowledge point to potential cardioprotective benefits such NF-κB signaling modulation, pro-inflammatory cytokine suppression, and endogenous antioxidant enzyme increase. Additionally, the study emphasizes methodological constraints, research gaps, and future directions for standardizing phytochemical analysis and medicinal validation. In order to inspire aspiring researchers and medical students to conduct creative, evidence-based investigations in phytomedicine, this publication attempts to bridge the gap between ethnopharmacological knowledge and contemporary biomedical research. While encouraging a stronger dedication to translational research and scientific inquiry, an understanding of Achyranthes aspera's therapeutic potential in cardiovascular health may lead to new opportunities for plant-based therapies in the management of chronic diseases.
Tiwari et al. (Tue,) studied this question.